Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab–sarotalocan sodium in a patient with oropharyngeal cancer: A case report

Background: Photoimmunotherapy (PIT) using cetuximab–sarotalocan sodium (CS) is a novel therapy for unresectable or locally recurrent head and neck squamous cell carcinoma (HNSCC). CS is a conjugate of cetuximab (monoclonal antibody targeting epidermal growth factor receptor [EGFR]) and IR700 (light...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sho Takuma, Masato Karayama, Risa Suzuki, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-01-01
Serija:	Respiratory Medicine Case Reports
Teme:	Cetuximab Cetuximab-sarotalocan sodium Photoimmunotherapy Drug-induced interstitial lung disease Lung injury Interstitial pneumonia
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2213007125000966
Oznake:	Označite Brez oznak, prvi označite!